Lipoprotein(a) and aortic stenosis
- 5 October 2021
- Vol. 108 (1), 9-10
- https://doi.org/10.1136/heartjnl-2021-320173
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Lipoprotein(a) has no major impact on calcification activity in patients with mild to moderate aortic valve stenosisHeart, 2021
- Lipoprotein(a) and Cardiovascular DiseaseClinical Chemistry, 2020
- Role of F-18-NaF-PET in assessing aortic valve calcification with age2020
- Lipoprotein(a), Oxidized Phospholipids, and Aortic Valve Microcalcification Assessed by 18F-Sodium Fluoride Positron Emission Tomography and Computed TomographyCJC Open, 2019
- Lipoprotein(a) and Oxidized Phospholipids Promote Valve Calcification in Patients With Aortic StenosisJournal of the American College of Cardiology, 2019
- WHY STEAL FROM ONE WHEN YOU CAN STEAL FROM TWO: A UNIQUE CASE OF CLASSIC SUBCLAVIAN STEAL SYNDROME WITH CONCOMITANT CORONARY SUBCLAVIAN STEAL SYNDROME IN THE POST CORONARY BYPASS PATIENTJournal of the American College of Cardiology, 2019
- Lipid Lowering on Progression of Mild to Moderate Aortic Stenosis: Meta-analysis of the Randomized Placebo-Controlled Clinical Trials on 2344 PatientsCanadian Journal of Cardiology, 2011
- Molecular Imaging Insights Into Early Inflammatory Stages of Arterial and Aortic Valve CalcificationCirculation Research, 2011
- Burden of valvular heart diseases: a population-based studyThe Lancet, 2006